Characteristics of Cerebrovascular Injury in the Hyperacute Phase After Induced Severe Subarachnoid Hemorrhage

Translational Stroke Research

Volumn 6, Issue 6, 2015, Pages 458-466

  Hasegawa, Yu ^a   Suzuki, Hidenori ^b   Uekawa, Ken ^a   Kawano, Takayuki ^a   Kim Mitsuyama, Shokei ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral blood flow; Hyperacute phase; Middle cerebral artery; Optic tract; Phosphorylated extracellular signal regulated kinase; Severe subarachnoid hemorrhage

Indexed keywords

ACETAZOLAMIDE; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERFORATION; BLOOD VESSEL REACTIVITY; BRAIN ARTERY; BRAIN BLOOD FLOW; BRAIN EDEMA; CELL DAMAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; ENDOVASCULAR SURGERY; EXTRAVASATION; HEART INJURY; MALE; MEMBRANE PERMEABILITY; MIDDLE CEREBRAL ARTERY; NONHUMAN; OPTIC TRACT; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; SUBARACHNOID HEMORRHAGE; UPREGULATION; ANIMAL; BLOOD GAS ANALYSIS; BRAIN CORTEX; COMPLICATION; DISEASE MODEL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; VASCULARIZATION;

ANIMALS; BLOOD GAS ANALYSIS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CEREBRAL ARTERIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 3; OPTIC TRACT; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE;

EID: 84946474352     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-015-0423-9     Document Type: Article

References (39)

1. Frontera JA, Ahmed W, Zach V, Jovine M, Tanenbaum L, Sehba F, et al. Acute ischaemia after subarachnoid haemorrhage, relationship with early brain injury and impact on outcome: a prospective quantitative MRI study. J Neurol Neurosurg Psychiatry. 2015;86:71–8.
2. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke. 1995;26:1086–91. discussion 1091–2.
3. Povlsen GK, Johansson SE, Larsen CC, Samraj AK, Edvinsson L. Early events triggering delayed vasoconstrictor receptor upregulation and cerebral ischemia after subarachnoid hemorrhage. BMC Neurosci. 2013;14:34.
4. Bederson JB, Levy AL, Ding WH, Kahn R, DiPerna CA, Jenkins 3rd AL, et al. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery. 1998;42:352–60. discussion 360–2.
5. Bederson JB, Connolly Jr ES, Batjer HH, Dacey RG, Dion JE, Diringer MN, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.
6. Huang J, van Gelder JM. The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery. 2002;51:1101–5. discussion 1105–7.
7. Chen S, Li Q, Wu H, Krafft PR, Wang Z, Zhang JH. The harmful effects of subarachnoid hemorrhage on extracerebral organs. Biomed Res Int. 2014;2014:858496.
8. Zhao W, Ujiie H, Tamano Y, Akimoto K, Hori T, Takakura K. Sudden death in a rat subarachnoid hemorrhage model. Neurol Med Chir (Tokyo). 1999;39:735–41. discussion 741–3.
9. Sehba FA, Mostafa G, Friedrich Jr V, Bederson JB. Acute microvascular platelet aggregation after subarachnoid hemorrhage. J Neurosurg. 2005;102:1094–100.
10. Sehba FA, Mostafa G, Knopman J, Friedrich Jr V, Bederson JB. Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg. 2004;101:633–40.
11. Sehba FA, Schwartz AY, Chereshnev I, Bederson JB. Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2000;20:604–11.
12. Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev. 2007;54:34–66.
13. Maddahi A, Edvinsson L. Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J Neuroinflammation. 2010;7:14.
14. Suzuki H, Hasegawa Y, Kanamaru K, Zhang JH. Mechanisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in rats. Stroke. 2010;41:1783–90.
15. Suzuki H, Ayer R, Sugawara T, Chen W, Sozen T, Hasegawa Y, et al. Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats. Crit Care Med. 2010;38:612–8.
16. Hasegawa Y, Suzuki H, Altay O, Zhang JH. Preservation of tropomyosin-related kinase B (TrkB) signaling by sodium orthovanadate attenuates early brain injury after subarachnoid hemorrhage in rats. Stroke. 2011;42:477–83.
17. Uekawa K, Hasegawa Y, Ma M, Nakagawa T, Katayama T, Sueta D, et al. Rosuvastatin ameliorates early brain injury after subarachnoid hemorrhage via suppression of superoxide formation and nuclear factor-kappa B activation in rats. J Stroke Cerebrovasc Dis. 2014;23:1429–39.
18. Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, et al. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats. J Pharmacol Exp Ther. 2011;339:358–66.
19. Sugawara T, Ayer R, Jadhav V, Zhang JH. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods. 2008;167:327–34.
20. Hasegawa Y, Suzuki H, Nakagawa T, Uekawa K, Koibuchi N, Kawano T, Kim-Mitsuyama S. Assessment of the correlations between brain weight and brain edema in experimental subarachnoid hemorrhage. Acta Neurochir Suppl. in press.
21. Hasegawa Y, Nakagawa T, Uekawa K, Ma M, Lin B, Kusaka H, Katayama T, Sueta D, Toyama K, Koibuchi N, Kim-Mitsuyama S. Therapy with the combination of amlodipine and irbesartan has persistent preventative effects on stroke onset associated with BDNF preservation on cerebral vessels in hypertensive rats. Transl Stroke Res. in press.
22. Wu CH, Chi JC, Jerng JS, Lin SJ, Jan KM, Wang DL, et al. Transendothelial macromolecular transport in the aorta of spontaneously hypertensive rats. Hypertension. 1990;16:154–61.
23. Egashira Y, Hua Y, Keep RF, Xi G. Acute white matter injury after experimental subarachnoid hemorrhage: potential role of lipocalin 2. Stroke. 2014;45:2141–3.
24. Sehba FA, Friedrich Jr V, Makonnen G, Bederson JB. Acute cerebral vascular injury after subarachnoid hemorrhage and its prevention by administration of a nitric oxide donor. J Neurosurg. 2007;106:321–9.
25. Little JR, Kerr FW, Sundt Jr TM. Microcirculatory obstruction in focal cerebral ischemia. Relationship to neuronal alterations. Mayo Clin Proc. 1975;50:264–70.
26. Paljärvi L, Rehncrona S, Söderfeldt B, Olsson Y, Kalimo H. Brain lactic acidosis and ischemic cell damage: quantitative ultrastructural changes in capillaries of rat cerebral cortex. Acta Neuropathol. 1983;60:232–40.
27. Ansar S, Edvinsson L. Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhage. Stroke. 2008;39:185–90.
28. Ansar S, Eftekhari S, Waldsee R, Nilsson E, Nilsson O, Säveland H, et al. MAPK signaling pathway regulates cerebrovascular receptor expression in human cerebral arteries. BMC Neurosci. 2013;14:12.
29. Beg SA, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat. J Cereb Blood Flow Metab. 2006;26:846–56.
30. Henriksson M, Xu CB, Edvinsson L. Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br J Pharmacol. 2004;142:1155–61.
31. Maddahi A, Povlsen GK, Edvinsson L. Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway. J Neuroinflammation. 2012;9:274.
32. Reinprecht A, Czech T, Asenbaum S, Podreka I, Schmidbauer M. Low cerebrovascular reserve capacity in long-term follow-up after subarachnoid hemorrhage. Surg Neurol. 2005;64:116–20. discussion 121.
33. Offenhauser N, Windmüller O, Strong AJ, Fuhr S, Dreier JP. The gamut of blood flow responses coupled to spreading depolarization in rat and human brain: from hyperemia to prolonged ischemia. Acta Neurochir Suppl. 2011;110(Pt 1):119–24.
34. Shigeno T, Fritschka E, Brock M, Schramm J, Shigeno S, Cervoś-Navarro J. Cerebral edema following experimental subarachnoid hemorrhage. Stroke. 1982;13:368–79.
35. Gibbs JM, Wise RJ, Leenders KL, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet. 1984;1:310–4.
36. Powers WJ, Raichle ME. Positron emission tomography and its application to the study of cerebrovascular disease in man. Stroke. 1985;16:361–76.
37. Zhang JH. Vascular neural network in subarachnoid hemorrhage. Transl Stroke Res. 2014;5:423–8.
38. Larsen CC, Hansen-Schwartz J, Nielsen JD, Astrup J. Blood coagulation and fibrinolysis after experimental subarachnoid hemorrhage. Acta Neurochir (Wien). 2010;152:1577–81. discussion 1581.
39. Schwartz AY, Masago A, Sehba FA, Bederson JB. Experimental models of subarachnoid hemorrhage in the rat: a refinement of the endovascular filament model. J Neurosci Methods. 2000;96:161–7.